Latest Half Year Results News

Diversified United Investment Limited reported a modest profit increase for the half year ending December 2025, alongside a stable dividend and a proposed merger with Australian United Investment Company Limited.

Qube Holdings reported a robust half-year performance for FY26, with underlying revenue climbing 12.9% and a significant property sale boosting statutory profits. The company also announced a major acquisition agreement with Macquarie Asset Management, signaling a transformative phase ahead.

Aquirian Limited has reported a strong rebound to profitability in the half year ending December 2025, driven by robust revenue growth and strategic partnerships that position it for expansion in mining services.

Alliance Aviation Services reported a $105.8 million half-year loss driven by significant impairments on its Fokker fleet, even as revenue rose 7.9% on wet lease and aviation services growth. The company is executing a strategic turnaround including fleet renewal and operational realignment.

EVZ Limited has reported a robust half-year financial performance, with revenue rising 16.5% to $63.1 million and net profit after tax surging 191% to nearly $2 million. The company’s disciplined cash management and improved margins underpin this growth.

BTC Health reports a slight statutory loss in HY26 amid a 7% revenue dip, offset by strong growth in its cardio segment driven by key hospital contracts.

PWR Holdings Limited has reported a robust half-year performance with revenues climbing 27.8% and net profit rising 38.6%, underpinned by strategic expansion in motorsports and aerospace sectors. The company also announced a higher fully franked interim dividend of 3 cents per share.

FSA Group Limited has reported a robust half-year performance with a 68% jump in profit before tax and declared a fully franked interim dividend of 3.5 cents per share. The company forecasts continued growth in 2026, targeting up to $40 million in annual profit.

Harmoney Corp Limited reported a striking 166% rise in Cash NPAT to $6.1 million for the half-year ended December 2025, driven by robust loan originations and improved interest margins. The company’s scalable model and refinancing efforts underpin its strong financial momentum.

Arovella Therapeutics reported a 22% increase in half-year losses to $1.88 million while securing FDA acceptance of its IND application for lead asset ALA-101, paving the way for first-in-human trials.

Peet Limited has reported a robust half-year performance with statutory profit doubling and a significant dividend increase, underpinned by strong sales and settlements across key Australian markets.

McPherson’s Limited has confirmed a $3.3 million total tax benefit following amended assessments by the ATO, linked to deductible costs from a strategic alliance announced in 2022.